SCHEMBL7655949

SCHEMBL7655949

CCN(CC)c1cccc(NN)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
CYP3A4 P08684 3/20 0.53
S100B P04271 1/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
NOX1 Q9Y5S8 2/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
MAPT P10636 6/20 0.42
MAPK1 P28482 3/20 0.42
TSHR P16473 3/20 0.42
TP53 P04637 3/20 0.42
USP2 O75604 1/20 0.42
PKM P14618 1/20 0.42
MCL1 Q07820 1/20 0.42
HDAC4 P56524 2/20 0.41
MEF2D Q14814 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
PSMD14 O00487 1/20 0.41
RECQL P46063 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31657712 0.82 ALDH1A1 (0.55) ALDH1A1CYP3A4S100BMEN1KMT2A
SCHEMBL4377348 0.82 ALDH1A1 (0.55) ALDH1A1CYP3A4S100BMEN1KMT2A
SCHEMBL9799266 0.81 ALDH1A1 (0.53) ALDH1A1CYP3A4S100BMEN1KMT2A
SCHEMBL11732026 0.79 ALDH1A1 (0.54) ALDH1A1CYP3A4MEN1KMT2ANOX1
SCHEMBL1574035 0.79 ALDH1A1 (0.71) ALDH1A1CYP3A4S100BMEN1KMT2A
SCHEMBL1413227 0.78 ALDH1A1 (0.59) ALDH1A1CYP3A4S100BMEN1KMT2A
SCHEMBL29931735 0.78 ALDH1A1 (0.59) ALDH1A1CYP3A4S100BMEN1KMT2A
SCHEMBL11469366 0.78 ALDH1A1 (0.48) ALDH1A1CYP3A4MEN1KMT2AMAPT
SCHEMBL8942317 0.78 MAPT (0.54) ALDH1A1CYP3A4MEN1KMT2ANOX1
SCHEMBL11332567 0.77 ALDH1A1 (0.49) ALDH1A1CYP3A4MEN1KMT2ANOX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407120-B1 ADMINISTERING PYRIDINYLACETAMIDE OR PHENYLACETAMIDE DERIVATIVE TO TREAT CARDIOVASCULAR, EATING, SEXUAL, BRAIN, NERVOUS SYSTEM, GASTROINTESTINAL, UROGENITAL, PSYCHOLOGICAL, AND RESPIRATORY SYSTEM DISORDERS PFIZER INC. 2002-06-18 US disclosed
EP-1033366-A2 Amide derivatives useful as Neuropeptide Y (NPY) antagonists Pfizer Products Inc. (US) 2000-09-06 EP disclosed